LENZ THERAPEUTICS, INC. Capital Expenditures
LENZ THERAPEUTICS, INC. (LENZ) reported Capital Expenditures of $34.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-11
- LENZ THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $16.00K, a 93.33% decline year-over-year.
- LENZ THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $18.00K, a 83.64% decline year-over-year.
- LENZ THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $38.00K, a 74.50% decline year-over-year.
- LENZ THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $439.00K, a 136.02% increase year-over-year.
- LENZ THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $827.00K, a 76.71% increase from fiscal 2024.
- LENZ THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $468.00K, a 1460.00% increase from fiscal 2023.
- LENZ THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $30.00K, a 99.55% decline from fiscal 2022.
- LENZ THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $6.59M, a 14.88% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $34.00K 10-Q · filed 2026-08-11 | $72.00K derived: sum of 3 quarters · filed 2026-08-11 | $511.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $18.00K 10-Q · filed 2026-05-11 | $56.00K derived: sum of 2 quarters · filed 2026-05-11 | $495.00K derived: sum of 3 quarters · filed 2026-05-11 | $735.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $477.00K derived: sum of 2 quarters · filed 2026-03-24 | $717.00K derived: sum of 3 quarters · filed 2026-08-11 | $827.00K 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | $439.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $679.00K derived: sum of 2 quarters · filed 2026-08-11 | $789.00K 10-Q · filed 2025-11-05 | $938.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $240.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $350.00K 10-Q · filed 2026-08-11 | $499.00K derived: sum of 3 quarters · filed 2026-08-11 | $685.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $110.00K 10-Q · filed 2026-05-11 | $259.00K derived: sum of 2 quarters · filed 2026-05-11 | $445.00K derived: sum of 3 quarters · filed 2026-05-11 | $578.00K derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $335.00K derived: sum of 2 quarters · filed 2026-03-24 | $468.00K derived: sum of 3 quarters · filed 2026-03-24 | $468.00K 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | $186.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $319.00K derived: sum of 2 quarters · filed 2025-11-05 | $319.00K 10-Q · filed 2025-11-05 | $319.00K derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $133.00K 10-Q · filed 2025-07-30 | $133.00K derived: sum of 3 quarters · filed 2025-07-30 | $133.00K derived: sum of 4 quarters · filed 2025-07-30 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2025-05-07 | $0.00 derived: sum of 3 quarters · filed 2025-05-07 | $24.00K derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $0.00 derived: sum of 2 quarters · filed 2025-03-19 | $24.00K derived: sum of 3 quarters · filed 2025-03-19 | $30.00K 10-K · filed 2025-03-19 | $10.86M 10-K · filed 2024-02-27 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $24.00K derived: sum of 2 quarters · filed 2024-11-06 | $30.00K 10-Q · filed 2024-11-06 | $10.81M 10-Q · filed 2023-11-13 | $1.05M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $30.00K 10-Q · filed 2024-08-14 | $5.99M 10-Q · filed 2023-08-14 | $1.05M derived: sum of 3 quarters · filed 2024-08-14 | $1.97M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $6.00K 10-Q · filed 2024-05-08 | $383.00K 10-Q · filed 2023-05-11 | $1.03M derived: sum of 2 quarters · filed 2024-05-08 | $1.94M derived: sum of 3 quarters · filed 2024-05-08 | $3.33M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.94M derived: sum of 2 quarters · filed 2024-02-27 | $3.32M derived: sum of 3 quarters · filed 2024-02-27 | $6.59M 10-K · filed 2024-02-27 | ||||
| 2022-09-30 | $915.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.30M derived: sum of 2 quarters · filed 2023-11-13 | $5.57M 10-Q · filed 2023-11-13 | $6.55M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $4.66M 10-Q · filed 2023-08-14 | $5.64M derived: sum of 3 quarters · filed 2023-08-14 | $9.28M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $3.27M 10-Q · filed 2023-05-11 | $4.25M derived: sum of 2 quarters · filed 2023-05-11 | $7.89M derived: sum of 3 quarters · filed 2023-05-11 | $8.65M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $981.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $4.62M derived: sum of 2 quarters · filed 2023-03-20 | $5.38M derived: sum of 3 quarters · filed 2023-03-20 | $5.74M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $3.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $4.40M derived: sum of 2 quarters · filed 2022-11-09 | $4.76M 10-Q · filed 2022-11-09 | $5.37M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $763.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.12M 10-Q · filed 2022-08-11 | $1.74M derived: sum of 3 quarters · filed 2022-08-11 | $2.29M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $360.00K 10-Q · filed 2022-05-12 | $972.00K derived: sum of 2 quarters · filed 2022-05-12 | $1.53M derived: sum of 3 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $1.17M derived: sum of 2 quarters · filed 2022-03-21 | $1.54M 10-K · filed 2022-03-21 | |||||
| 2020-09-30 | $554.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $933.00K 10-Q · filed 2021-11-10 | ||||||
| 2020-06-30 | $379.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |